Literature DB >> 27197156

Exome-Scale Discovery of Hotspot Mutation Regions in Human Cancer Using 3D Protein Structure.

Collin Tokheim1, Rohit Bhattacharya1, Noushin Niknafs1, Derek M Gygax2, Rick Kim2, Michael Ryan2, David L Masica1, Rachel Karchin3.   

Abstract

The impact of somatic missense mutation on cancer etiology and progression is often difficult to interpret. One common approach for assessing the contribution of missense mutations in carcinogenesis is to identify genes mutated with statistically nonrandom frequencies. Even given the large number of sequenced cancer samples currently available, this approach remains underpowered to detect drivers, particularly in less studied cancer types. Alternative statistical and bioinformatic approaches are needed. One approach to increase power is to focus on localized regions of increased missense mutation density or hotspot regions, rather than a whole gene or protein domain. Detecting missense mutation hotspot regions in three-dimensional (3D) protein structure may also be beneficial because linear sequence alone does not fully describe the biologically relevant organization of codons. Here, we present a novel and statistically rigorous algorithm for detecting missense mutation hotspot regions in 3D protein structures. We analyzed approximately 3 × 10(5) mutations from The Cancer Genome Atlas (TCGA) and identified 216 tumor-type-specific hotspot regions. In addition to experimentally determined protein structures, we considered high-quality structural models, which increase genomic coverage from approximately 5,000 to more than 15,000 genes. We provide new evidence that 3D mutation analysis has unique advantages. It enables discovery of hotspot regions in many more genes than previously shown and increases sensitivity to hotspot regions in tumor suppressor genes (TSG). Although hotspot regions have long been known to exist in both TSGs and oncogenes, we provide the first report that they have different characteristic properties in the two types of driver genes. We show how cancer researchers can use our results to link 3D protein structure and the biologic functions of missense mutations in cancer, and to generate testable hypotheses about driver mechanisms. Our results are included in a new interactive website for visualizing protein structures with TCGA mutations and associated hotspot regions. Users can submit new sequence data, facilitating the visualization of mutations in a biologically relevant context. Cancer Res; 76(13); 3719-31. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27197156      PMCID: PMC4930736          DOI: 10.1158/0008-5472.CAN-15-3190

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  48 in total

1.  Protein structure prediction and structural genomics.

Authors:  D Baker; A Sali
Journal:  Science       Date:  2001-10-05       Impact factor: 47.728

2.  Rapid detection of positive selection in genes and genomes through variation clusters.

Authors:  Andreas Wagner
Journal:  Genetics       Date:  2007-07-01       Impact factor: 4.562

3.  Comprehensive assessment of cancer missense mutation clustering in protein structures.

Authors:  Atanas Kamburov; Michael S Lawrence; Paz Polak; Ignaty Leshchiner; Kasper Lage; Todd R Golub; Eric S Lander; Gad Getz
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-21       Impact factor: 11.205

Review 4.  New and emerging HDAC inhibitors for cancer treatment.

Authors:  Alison C West; Ricky W Johnstone
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

5.  TFIIH with inactive XPD helicase functions in transcription initiation but is defective in DNA repair.

Authors:  G S Winkler; S J Araújo; U Fiedler; W Vermeulen; F Coin; J M Egly; J H Hoeijmakers; R D Wood; H T Timmers; G Weeda
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

6.  Inhibition of poly(ADP-ribose) glycohydrolase (PARG) specifically kills BRCA2-deficient tumor cells.

Authors:  Catherine Fathers; Ross M Drayton; Svetlana Solovieva; Helen E Bryant
Journal:  Cell Cycle       Date:  2012-03-01       Impact factor: 4.534

7.  Integrated genomic characterization of papillary thyroid carcinoma.

Authors: 
Journal:  Cell       Date:  2014-10-23       Impact factor: 41.582

8.  AURKA is one of the downstream targets of MAPK1/ERK2 in pancreatic cancer.

Authors:  T Furukawa; N Kanai; H O Shiwaku; N Soga; A Uehara; A Horii
Journal:  Oncogene       Date:  2006-03-13       Impact factor: 9.867

9.  Identification of candidate oncogenes in human colorectal cancers with microsatellite instability.

Authors:  Alexandra E Gylfe; Johanna Kondelin; Mikko Turunen; Heikki Ristolainen; Riku Katainen; Esa Pitkänen; Eevi Kaasinen; Ville Rantanen; Tomas Tanskanen; Markku Varjosalo; Heli Lehtonen; Kimmo Palin; Minna Taipale; Jussi Taipale; Laura Renkonen-Sinisalo; Heikki Järvinen; Jan Böhm; Jukka-Pekka Mecklin; Ari Ristimäki; Outi Kilpivaara; Sari Tuupanen; Auli Karhu; Pia Vahteristo; Lauri A Aaltonen
Journal:  Gastroenterology       Date:  2013-05-16       Impact factor: 22.682

Review 10.  The Ras protein superfamily: evolutionary tree and role of conserved amino acids.

Authors:  Ana Maria Rojas; Gloria Fuentes; Antonio Rausell; Alfonso Valencia
Journal:  J Cell Biol       Date:  2012-01-23       Impact factor: 10.539

View more
  42 in total

1.  PertInInt: An Integrative, Analytical Approach to Rapidly Uncover Cancer Driver Genes with Perturbed Interactions and Functionalities.

Authors:  Shilpa Nadimpalli Kobren; Bernard Chazelle; Mona Singh
Journal:  Cell Syst       Date:  2020-07-14       Impact factor: 10.304

2.  Comparison of algorithms for the detection of cancer drivers at subgene resolution.

Authors:  Eduard Porta-Pardo; Atanas Kamburov; David Tamborero; Tirso Pons; Daniela Grases; Alfonso Valencia; Nuria Lopez-Bigas; Gad Getz; Adam Godzik
Journal:  Nat Methods       Date:  2017-07-17       Impact factor: 28.547

3.  Modified Vaccinia virus Ankara-based vaccines in the era of personalized immunotherapy of cancer.

Authors:  Kaïdre Bendjama; Eric Quemeneur
Journal:  Hum Vaccin Immunother       Date:  2017-08-28       Impact factor: 3.452

4.  Tissue-Specific Signaling Networks Rewired by Major Somatic Mutations in Human Cancer Revealed by Proteome-Wide Discovery.

Authors:  Junfei Zhao; Feixiong Cheng; Zhongming Zhao
Journal:  Cancer Res       Date:  2017-03-31       Impact factor: 12.701

5.  Systematic Functional Annotation of Somatic Mutations in Cancer.

Authors:  Patrick Kwok-Shing Ng; Jun Li; Kang Jin Jeong; Shan Shao; Hu Chen; Yiu Huen Tsang; Sohini Sengupta; Zixing Wang; Venkata Hemanjani Bhavana; Richard Tran; Stephanie Soewito; Darlan Conterno Minussi; Daniela Moreno; Kathleen Kong; Turgut Dogruluk; Hengyu Lu; Jianjiong Gao; Collin Tokheim; Daniel Cui Zhou; Amber M Johnson; Jia Zeng; Carman Ka Man Ip; Zhenlin Ju; Matthew Wester; Shuangxing Yu; Yongsheng Li; Christopher P Vellano; Nikolaus Schultz; Rachel Karchin; Li Ding; Yiling Lu; Lydia Wai Ting Cheung; Ken Chen; Kenna R Shaw; Funda Meric-Bernstam; Kenneth L Scott; Song Yi; Nidhi Sahni; Han Liang; Gordon B Mills
Journal:  Cancer Cell       Date:  2018-03-12       Impact factor: 31.743

6.  Comprehensive characterization of protein-protein interactions perturbed by disease mutations.

Authors:  Feixiong Cheng; Junfei Zhao; Yang Wang; Weiqiang Lu; Zehui Liu; Yadi Zhou; William R Martin; Ruisheng Wang; Jin Huang; Tong Hao; Hong Yue; Jing Ma; Yuan Hou; Jessica A Castrillon; Jiansong Fang; Justin D Lathia; Ruth A Keri; Felice C Lightstone; Elliott Marshall Antman; Raul Rabadan; David E Hill; Charis Eng; Marc Vidal; Joseph Loscalzo
Journal:  Nat Genet       Date:  2021-02-08       Impact factor: 38.330

7.  CRAVAT 4: Cancer-Related Analysis of Variants Toolkit.

Authors:  David L Masica; Christopher Douville; Collin Tokheim; Rohit Bhattacharya; RyangGuk Kim; Kyle Moad; Michael C Ryan; Rachel Karchin
Journal:  Cancer Res       Date:  2017-11-01       Impact factor: 12.701

8.  Comprehensive Analysis of Constraint on the Spatial Distribution of Missense Variants in Human Protein Structures.

Authors:  R Michael Sivley; Xiaoyi Dou; Jens Meiler; William S Bush; John A Capra
Journal:  Am J Hum Genet       Date:  2018-02-15       Impact factor: 11.025

9.  Exploiting ion channel structure to assess rare variant pathogenicity.

Authors:  Brett M Kroncke; Tao Yang; Prince Kannankeril; M Benjamin Shoemaker; Dan M Roden
Journal:  Heart Rhythm       Date:  2018-01-09       Impact factor: 6.343

Review 10.  A compendium of mutational cancer driver genes.

Authors:  Francisco Martínez-Jiménez; Ferran Muiños; Inés Sentís; Jordi Deu-Pons; Iker Reyes-Salazar; Claudia Arnedo-Pac; Loris Mularoni; Oriol Pich; Jose Bonet; Hanna Kranas; Abel Gonzalez-Perez; Nuria Lopez-Bigas
Journal:  Nat Rev Cancer       Date:  2020-08-10       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.